525 related articles for article (PubMed ID: 27997653)
21. Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study Group.
Bodsworth NJ; Crooks RJ; Borelli S; Vejlsgaard G; Paavonen J; Worm AM; Uexkull N; Esmann J; Strand A; Ingamells AJ; Gibb A
Genitourin Med; 1997 Apr; 73(2):110-6. PubMed ID: 9215092
[TBL] [Abstract][Full Text] [Related]
22. Once-daily valacyclovir to reduce the risk of transmission of genital herpes.
Corey L; Wald A; Patel R; Sacks SL; Tyring SK; Warren T; Douglas JM; Paavonen J; Morrow RA; Beutner KR; Stratchounsky LS; Mertz G; Keene ON; Watson HA; Tait D; Vargas-Cortes M;
N Engl J Med; 2004 Jan; 350(1):11-20. PubMed ID: 14702423
[TBL] [Abstract][Full Text] [Related]
23. Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group.
Patel R; Bodsworth NJ; Woolley P; Peters B; Vejlsgaard G; Saari S; Gibb A; Robinson J
Genitourin Med; 1997 Apr; 73(2):105-9. PubMed ID: 9215091
[TBL] [Abstract][Full Text] [Related]
24. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
Handsfield HH; Warren T; Werner M; Phillips JA
Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
[TBL] [Abstract][Full Text] [Related]
25. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
Warren T; Harris J; Brennan CA
Clin Infect Dis; 2004 Nov; 39 Suppl 5():S258-66. PubMed ID: 15494897
[TBL] [Abstract][Full Text] [Related]
27. Reducing the risk of transmitting genital herpes: advances in understanding and therapy.
Leone P
Curr Med Res Opin; 2005 Oct; 21(10):1577-82. PubMed ID: 16238897
[TBL] [Abstract][Full Text] [Related]
28. The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures.
Miller CS; Cunningham LL; Lindroth JE; Avdiushko SA
J Am Dent Assoc; 2004 Sep; 135(9):1311-8. PubMed ID: 15493396
[TBL] [Abstract][Full Text] [Related]
29. The effect of valacyclovir on HIV and HSV-2 in HIV-infected persons on antiretroviral therapy with previously unrecognised HSV-2.
Van Wagoner N; Geisler WM; Bachmann LH; Hook EW
Int J STD AIDS; 2015 Jul; 26(8):574-81. PubMed ID: 25147236
[TBL] [Abstract][Full Text] [Related]
30. High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a randomized, crossover trial.
Mugwanya K; Baeten JM; Mugo NR; Irungu E; Ngure K; Celum C
J Infect Dis; 2011 Dec; 204(12):1912-7. PubMed ID: 21998479
[TBL] [Abstract][Full Text] [Related]
31. Interventions for men and women with their first episode of genital herpes.
Heslop R; Roberts H; Flower D; Jordan V
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010684. PubMed ID: 27575957
[TBL] [Abstract][Full Text] [Related]
32. Impact of suppressive herpes therapy on genital HIV-1 RNA among women taking antiretroviral therapy: a randomized controlled trial.
Ouedraogo A; Nagot N; Vergne L; Konate I; Weiss HA; Defer MC; Foulongne V; Sanon A; Andonaba JB; Segondy M; Mayaud P; Van de Perre P
AIDS; 2006 Nov; 20(18):2305-13. PubMed ID: 17117016
[TBL] [Abstract][Full Text] [Related]
33. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group.
Fife KH; Barbarash RA; Rudolph T; Degregorio B; Roth R
Sex Transm Dis; 1997 Sep; 24(8):481-6. PubMed ID: 9293612
[TBL] [Abstract][Full Text] [Related]
34. Oral and Vaginal Tenofovir for Genital Herpes Simplex Virus Type 2 Shedding in Immunocompetent Women: A Double-Blind, Randomized, Cross-over Trial.
Bender Ignacio RA; Perti T; Magaret AS; Rajagopal S; Stevens CE; Huang ML; Selke S; Johnston C; Marrazzo J; Wald A
J Infect Dis; 2015 Dec; 212(12):1949-56. PubMed ID: 26044291
[TBL] [Abstract][Full Text] [Related]
35. Prevention of perinatal herpes: prophylactic antiviral therapy?
Scott LL
Clin Obstet Gynecol; 1999 Mar; 42(1):134-48; quiz 174-5. PubMed ID: 10073307
[TBL] [Abstract][Full Text] [Related]
36. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection.
Hollier LM; Wendel GD
Cochrane Database Syst Rev; 2008 Jan; (1):CD004946. PubMed ID: 18254066
[TBL] [Abstract][Full Text] [Related]
37. Famciclovir reduces viral mucosal shedding in HSV-seropositive persons.
Leone P; Warren T; Hamed K; Fife K; Wald A
Sex Transm Dis; 2007 Nov; 34(11):900-7. PubMed ID: 17538513
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy.
Kimberlin DF; Weller S; Whitley RJ; Andrews WW; Hauth JC; Lakeman F; Miller G
Am J Obstet Gynecol; 1998 Oct; 179(4):846-51. PubMed ID: 9790357
[TBL] [Abstract][Full Text] [Related]
39. Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects.
DeJesus E; Wald A; Warren T; Schacker TW; Trottier S; Shahmanesh M; Hill JL; Brennan CA;
J Infect Dis; 2003 Oct; 188(7):1009-16. PubMed ID: 14513421
[TBL] [Abstract][Full Text] [Related]
40. Self-collected genital swabs compared with cervicovaginal lavage for measuring HIV-1 and HSV-2 and the effect of acyclovir on viral shedding.
McNicholl JM; Leelawiwat W; Whitehead S; Hanson DL; Evans-Strickfaden T; Cheng CY; Chonwattana W; Mueanpai F; Kittinunvorakoon C; Markowitz L; Dunne EF
Int J STD AIDS; 2017 Mar; 28(4):372-379. PubMed ID: 27179350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
